E. Spata
2 Papers
2 Citations
E. Spata is an academic researcher. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
Pamela Minicozzi,Massimo Vicentini,Kaire Innos,Clara Castro,Marcela Guevara,Fabrizio Stracci,MaCarmen Carmona-Garcia,Miguel Rodríguez-Barranco,Miguel Rodríguez-Barranco,Katrijn Vanschoenbeek,Elisabetta Rapiti,Alexander Katalinic,Rafael Marcos-Gragera,Liesbet Van Eycken,María José Sánchez,Magdalena Bielska-Lasota,Paolo Giorgi Rossi,Milena Sant,L. Van Eycken,K. Henau,T. Grozeva,Zdravka Valerianova,K. Innos,Margit Mägi,Véronique Bouvier,G. Launoy,Valérie Jooste,Sébastien Normand,M. Robaszkiewicz,Anne Marie Bouvier,J. Faivre,V. Babaev,A. Katalinic,E.J. Ólafsdóttir,Laufey Tryggvadottir,C. Amati,P. Baili,S. Bonfarnuzzo,E. Meneghini,P. Minicozzi,G. Moretti,M. Sant,Claudia Cirilli,G. Carrozzi,E. Spata,R. Tumino,P. Giorgi Rossi,M. Vicentini,F. Stracci,Fortunato Bianconi,Paolo Contiero,Giovanna Tagliabue,W. Kycler,M. Oko,P. Macek,J. Smok-Kalwat,M. Bielska-Lasota,Maria José Bento,C. Castro,A. Mayer-da-Silva,Ana Miranda,M. Primic Žakelj,K. Jarm,E. Almar,A. Mateos,J. Bidaurrazaga,M. de la Cruz,C. Alberich,Ana Torrella-Ramos,A.I. Marcos Navarro,R. Jiménez Chillarón,M.C. Carmona-Garcia,R. Marcos-Gragera,M. Rodriguez-Barranco,M-J Sanchez,Eva Ardanaz,M. Guevara,Christine Bouchardy,E. Fournier +78 more
TL;DR: The data indicate that promptly-administered postoperative chemotherapy maximizes its benefit, and that careful assessment of comorbidities is important before treatment.
14
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study.
Anne-Marie Bouvier,Valérie Jooste,Maria José Sanchez-Perez,Maria José Bento,Jessica Rocha Rodrigues,Rafael Marcos-Gragera,Maria Carmen Carmona-Garcia,Miguel Angel Luque-Fernandez,Pamela Minicozzi,Véronique Bouvier,Véronique Bouvier,Kaire Innos,Milena Sant,L. Van Eycken,K. Henau,T. Grozeva,Zdravka Valerianova,K. Innos,Margit Mägi,V. Bouvier,G. Launoy,M. Robaszkiewicz,Anne Marie Bouvier,V. Jooste,V. Babaev,Alexander Katalinic,Elinborg J Olafsdottir,Laufey Tryggvadottir,C. Amati,P. Baili,S. Bonfarnuzzo,C. Margutti,Elisabetta Meneghini,Pamela Minicozzi,G. Moretti,M. Sant,Claudia Cirilli,G. Carrozzi,E. Spata,R. Tumino,P. Giorgi Rossi,Massimo Vicentini,Fabrizio Stracci,Fortunato Bianconi,Paolo Contiero,Giovanna Tagliabue,W. Kycler,M. Oko,P. Macek,J. Smok-Kalwat,Magdalena Bielska-Lasota,M.J. Bento,J Rodrigues,A. Mayer-da-Silva,Ana Miranda,M. Primic-Žakelj,K. Jarm,E. Almar,A. Mateos,J. Bidaurrazaga,M. de la Cruz,C. Alberich,Ana Torrella-Ramos,J.M. Díaz García,AI Marcos-Navarro,C. Carmona-Garcia,R. Marcos-Gragera,M.A. Luque-Fernandez,M.J. Sánchez-Pérez,Eva Ardanaz,Marcela Guevara,Christine Bouchardy,E. Fournier +72 more
TL;DR: In this article, a European comparison of the management and prognosis of metastatic colorectal cancers was made using a logistic regression model, where factors associated with chemotherapy administration were identified through logistic regressions and crude probabilities of death related to cancer and other causes using a flexible cumulative hazard model.
5